Hunter David J, Nicolson Philippa J A, Little Christopher B, Robbins Sarah R, Wang Xia, Bennell Kim L
Department of Rheumatology, Royal North Shore Hospital and Institute of Bone and Joint Research, Kolling Institute, University of Sydney, St Leonards, Sydney, New South Wales, 2065, Australia.
Rheumatology Department, Royal North Shore Hospital, Reserve Road, St Leonards, New South Wales, 2065, Australia.
BMC Musculoskelet Disord. 2019 Feb 13;20(1):74. doi: 10.1186/s12891-019-2455-x.
There is a pressing need to enhance osteoarthritis (OA) research to find ways of alleviating its enormous individual and societal impact due to the high prevalence, associated disability, and extensive costs.
Potential research priorities and initial rankings were pre-identified via surveys and the 1000Minds process by OA consumers and the research community. The OA Summit was held to decide key research priorities that match the strengths and expertise of the Australian OA research community and align with the needs of consumers. Facilitated breakout sessions were conducted to identify initiatives and strategies to advance OA research into agreed priority areas, and foster collaboration in OA research by forming research networks.
From the pre-Summit activities, the three research priority areas identified were: treatment adherence and behaviour change, disease modification, and prevention of OA. Eighty-five Australian and international leading OA experts participated in the Summit, including specialists, allied health practitioners, researchers from all states of Australia representing both universities and medical research institutes; representatives from Arthritis Australia, health insurers; and persons living with OA. Through the presentations and discussions during the Summit, there was a broad consensus on the OA research priorities across stakeholders and how these can be supported across government, industry, service providers and consumers.
The Australian OA Summit brought consumers, experts and opinion leaders together to identify OA research priorities, to enhance current research efforts by fostering collaboration that offer the greatest potential for alleviating the disease burden.
由于骨关节炎(OA)患病率高、相关残疾问题以及高昂的成本,对个人和社会造成了巨大影响,因此迫切需要加强OA研究,以找到减轻这些影响的方法。
通过调查以及由OA消费者和研究界参与的1000Minds流程,预先确定了潜在的研究重点和初步排名。举办了OA峰会,以确定与澳大利亚OA研究界的优势和专业知识相匹配且符合消费者需求的关键研究重点。开展了分组讨论会议,以确定将OA研究推进到商定的优先领域的举措和策略,并通过形成研究网络促进OA研究领域的合作。
从峰会前的活动中确定的三个研究优先领域为:治疗依从性和行为改变、疾病修饰以及OA的预防。85位澳大利亚和国际领先的OA专家参加了峰会,包括专科医生、专职医疗人员、来自澳大利亚所有州的代表大学和医学研究所的研究人员;澳大利亚关节炎协会、健康保险公司的代表;以及OA患者。通过峰会期间的演讲和讨论,各利益相关者就OA研究重点以及如何在政府、行业、服务提供者和消费者之间提供支持达成了广泛共识。
澳大利亚OA峰会将消费者、专家和意见领袖聚集在一起,确定OA研究重点,通过促进合作来加强当前的研究工作,从而为减轻疾病负担提供最大潜力。